Use of the mannan receptor to selectively target vaccine antigens for processing and antigen presentation through the MHC class I and class II pathways.
Davis WC, Konzek RL, Haas K, Estes DM, Hamilton MJ, Call DR, Apostolopoulos V, McKenzie IF. Use of the mannan receptor to selectively target vaccine antigens for processing and antigen presentation through the MHC class I and class II pathways. Ann N Y Acad Sci. 2002 Oct; 969:119-25.